ArticleHeart Asia2013
The healthcare burden of hypertension in Asia.
Article in Heart Asia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis.International journal of clinical pharmacy · 2021Pooled it
- Trial
- Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2017Trial
- Investigation of risk factors for osteoporosis with a focus on hypertension and estimation of the causal effect of hypertension on osteoporosis using causal forest.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Physical activity interventions implemented for older people in Sub-Saharan Africa: a scoping review.BMJ open · 2024Article
- Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024Review
- Association between hypertension grades and cancer mortality among Japanese men and women.Cancer causes & control : CCC · 2024Article
- Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.Journal of clinical hypertension (Greenwich, Conn.) · 2022Review
- Article
- Cardiovascular risk factors of airport visitors in India: results from a nation-wide campaign.Journal of clinical hypertension (Greenwich, Conn.) · 2022Article
- Isolated systolic hypertension in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2021Review
- Dietary Salt-Related Determinants of Hypertension in Rural Northern Thailand.International journal of environmental research and public health · 2021Article
- Doxorubicin and subsequent risk of cardiovascular diseases among survivors of diffuse large B-cell lymphoma in Hong Kong.Blood advances · 2020Article
- Prevalence, Treatment, Control and Monitoring of Hypertension: A Nationwide Community-Based Survey in Taiwan, 2017.Acta Cardiologica Sinica · 2020Article
- Prevalence and predisposing factors for self-reported hypertension in Bhutanese adults.Nepal journal of epidemiology · 2020Article
- An overview of hypertension and cardiac involvement in Asia: Focus on heart failure.Journal of clinical hypertension (Greenwich, Conn.) · 2020Review
- Hypertension and Dementia: A comprehensive review from the HOPE Asia Network.Journal of clinical hypertension (Greenwich, Conn.) · 2019Review
- Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients.International journal of hypertension · 2019Article
- Echoes from Gaea, Poseidon, Hephaestus, and Prometheus: environmental risk factors for high blood pressure.Journal of human hypertension · 2018Review
- Twenty-four-hour systolic blood pressure variability and renal function decline in elderly male hypertensive patients with well-controlled blood pressure.Clinical interventions in aging · 2018Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the leading global risk for mortality, hypertension (HT) is a common healthcare problem in the world. The total number of patients with HT is likely to grow in the next few decades as the population age and the prevalence of obesity and diabetes increase. HT, as a major modifiable risk factor for cardiovascular disease, results in more deaths than any other risk factors, including diabetes and cigarette smoking. High prevalence, inadequate awareness, suboptimal treatment and low rate of achieving guideline-recommended target blood pressure control are key factors leading to severe cardiovascular complications that impose a heavy socioeconomic burden, especially in developing countries. Asia is the world's largest and most populous continent with approximately 4.3 billion people, hosting 60% of the world's current human population, and has a high growth rate. Asia differs very widely from the West with regard to ethnic groups, cultures, environments, economics, historical ties and government systems. Therefore, the purpose of this review is to comprehensively summarise the epidemiology, treatment practice and the status of control of HT in different Asian countries in order to guide the future prevention and management in this part of the world.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.